Related Experiment Videos
[Pulmonary embolization from migration of sclerotherapy material]
A Nassif1, V Coevoet, A Resten
1Hôpital Antoine Béclère, Service de Radiologie, 157, rue de la Porte de Trivaux, BP 405, 92141 Clamart Cedex.
Journal De Radiologie
|June 21, 2001
Summary
A rare complication of esophageal variceal sclerotherapy is pulmonary embolism, caused by the migration of the injected sclerosing agent. This case highlights an unusual cause of pulmonary embolism, emphasizing the need for awareness among clinicians.
Area of Science:
- Gastroenterology
- Cardiology
- Pulmonology
Background:
- Esophageal varices are a serious complication of liver disease.
- Sclerotherapy is a common treatment for esophageal varices.
- Complications of sclerotherapy can include systemic embolism.
Observation:
- A patient developed pulmonary embolism after undergoing esophageal variceal sclerotherapy.
- The pulmonary embolism was attributed to the migration of the injected sclerosing agent.
Findings:
- The migration of an esophageal variceal sclerosing agent can lead to pulmonary embolism.
- This specific complication, though infrequent, is underreported in medical literature.
Implications:
- Clinicians should be aware of the potential for systemic migration of sclerosing agents.
- This case underscores the importance of careful injection technique and patient monitoring post-sclerotherapy.
- Further investigation into the mechanisms and prevention of this complication may be warranted.